Abstract 5336: Dissecting the molecular mechanism of trastuzumab resistance in stage IV HER2-positive gastric cancer patientsQi Xu, Jieer Ying, Jing‐Jing Li et al.|Cancer Research|2022Cited by 0
An active trend of immunotherapy combination regimen as second-line therapy for advanced biliary tract cancer: A multicenter retrospective study.Jieer Ying, Yuemiao Chen, Jing‐Jing Li et al.|Journal of Clinical Oncology|2023Cited by 0
Biliary Tract Cancer in Eastern China: A Multicenter Retrospective AnalysisYiwen Zhou, Jieer Ying, Jiaojiao Ni et al.|SSRN Electronic Journal|2025Cited by 0